HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is a Equity Scheme - Sectoral/ Thematic managed by HDFC Mutual Fund. Review NAV history, returns and risk measures before making an investment decision.
- Latest NAV
- ₹21.755
- NAV as of
- 21 Jul 2026
- 1Y return
- 21.27%
- 3Y CAGR
- Not available
- 5Y CAGR
- Not available
- Sharpe ratio
- 1.6
- Max drawdown
- 15.72%
- Category rank
- #10 of 257